Spyros A. Kalams

Infectious Disease · Vanderbilt University Medical Center

Credentials: · · ·

History

Tennessee CFAR: 2027 National Program Meeting
National Institute of Allergy and Infectious Diseases · P30
Project lead · $3.6M · Vanderbilt University Medical Center
2015–2030
Mapping T Cell Recognition of Mtb: Beyond Immunodominant Peptides
National Institute of Allergy and Infectious Diseases · R21
Contact PI · $262.5K · Vanderbilt University Medical Center
2026–2028
Vanderbilt HIV Clinical Trials Unit (CTU)
National Institute of Allergy and Infectious Diseases · UM1
PI · $30M · Vanderbilt University Medical Center
2007–2027
Vanderbilt Infection Pathogenesis and Epidemiology Research Training Program
National Institute of Allergy and Infectious Diseases · T32
Contact PI · $3.8M · Vanderbilt University Medical Center
1995–2027

Senescent Immunity in Elders and Vaccine Responses (SILVER)
Principal investigator · Completed · Phase 4
Vanderbilt University Medical Center
2019–2020
Safety and Immunogenicity of pDNA Vaccines Expressing HIV M Group p24^Gag Conserved Elements and/or p55^Gag, Administered With IL-12 pDNA
Study chair · Completed · Phase 1
National Institute of Allergy and Infectious Diseases (NIAID)
2017–2020
Safety of and Immune Response to Two Different HIV Vaccines, Each Followed by a Adenoviral Vaccine Boost, in HIV Uninfected Adults
Study chair · Completed · Phase 1
National Institute of Allergy and Infectious Diseases (NIAID)
2006–2007
Safety of and Immune Response to a New HIV Vaccine: HIV CTL MEP
Study chair · Completed · Phase 1
National Institute of Allergy and Infectious Diseases (NIAID)
2004–2006